Illumina had three patents in cybersecurity during Q2 2024. Illumina Inc’s patent filed in Q2 2024 introduces a new method for storing, analyzing, and accessing biological data in a cloud computing environment. This approach allows for uploading sequence data during a sequencing run, reducing on-site storage needs. Analysis can also be performed in the cloud, with permissions for sharing and the ability for authorized users to modify or annotate the data. GlobalData’s report on Illumina gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Illumina Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Illumina had no grants in cybersecurity as a theme in Q2 2024.

Recent Patents

Application: Cloud computing environment for biological data (Patent ID: US20240120093A1)

The patent filed by Illumina Inc. describes a system and method for storing, analyzing, and accessing biological data in a cloud computing environment. The system involves a cloud computing environment that communicates with sequencing devices to receive and store sequence data generated during sequencing runs. The data can be analyzed, modified, and shared within the cloud environment based on permissions set by the originating sequencing device. Additionally, the system allows for secondary users to annotate the sequence data with proper authorization.

The system includes a cloud computing environment with a server that communicates with sequencing devices to store sequence data during generation. The data can be analyzed, assembled into genomes, and shared based on user instructions and permissions. The cloud environment also allows for annotations by secondary users, with quality control measures in place to ensure the accuracy and relevance of the annotations. Furthermore, the system enables secondary users to access the sequence data based on permissions set by the originator, ensuring secure and controlled sharing of biological data for analysis and research purposes.

To know more about GlobalData’s detailed insights on Illumina, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.